选择性环氧合酶2抑制剂对子宫内膜癌细胞增殖能力及蛋白质表达谱的影响
摘要
细胞的增殖与凋亡失衡将导致细胞生物学行为异常,甚至导致肿瘤的发生。近年来对肿瘤的研究表明,环氧合酶2(cyclooxygenase-2,COX-2)有促进肿瘤细胞增殖及防止凋亡的作用,COX-2抑制剂可用于结直肠癌的治疗,但其机制尚不完全清楚。有关COX-2与子宫内膜癌(endometrial cancer,EC)细胞增殖、凋亡的相关报道不多见,COX-2抑制剂与EC常用化疗药物顺铂是否存在协同关系的报道也不多见。本研究从细胞水平探讨选择性COX-2抑制剂——NS-398与顺铂联用对EC细胞增殖的抑制作用,以及从蛋白质水平研究COX-2抑制剂在EC细胞中的潜在作用靶点,为探索有效、低毒的EC治疗方案奠定基础。
出处
《中华妇产科杂志》
CAS
CSCD
北大核心
2009年第6期463-465,共3页
Chinese Journal of Obstetrics and Gynecology
基金
湖南省自然科学基金(07JJ3043)
参考文献13
-
1Anderson L, Seihamer J. A comparsion of selected mRNA and protein abundances in human liver. Electrophoresis, 1997, 18: 533-537.
-
2Li HL, Zhang HW, Chen DD, et al. JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells. Acta Pharmacol Sin, 2002, 23:631-637.
-
3Shaik MS, Chatterjee A, Jackson T, et al. Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors. Int J Cancer, 2006, 118:396-404.
-
4Odabaei G, Chatterjee D, Jazirehi AR, et al. Raf-1 kinase inhibitor protein : structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res, 2004, 91 : 169- 200.
-
5徐刚,吴恺,王兴鹏,赵崧.塞来昔布与吉西他滨合用对胰腺癌的抑制作用及其机制[J].中华医学杂志,2005,85(14):986-991. 被引量:17
-
6Mandal M, Vadlamudi R, Nguyen D, et al. Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J Biol Chem, 2001, 276:9699-9704.
-
7Lynch M, Chen L, Ravitz MJ, polypyrimidine element in the et al. hnRNP K binds a core eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation. Mol Cell Biol, 2005,25 : 6436-6453.
-
8Verrills NM, Walsh BJ, Cobon GS, et al. Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. J Biol Chem, 2003, 278:45082-45093.
-
9叶丽虹,秦宵然,张晓东,齐众,钱令嘉,侯志波,王洪辉,徐少峰.原肌球蛋白、波形纤维蛋白和热休克蛋白70在肝癌转移亚细胞中表达上调[J].中国生物化学与分子生物学报,2005,21(2):244-249. 被引量:14
-
10Yang WL, Nair DG, Makizumi R, et al. Heat shock protein 70 is induced in mouse human colon tumor xenografts after sublethal radiofrequency ablation. Ann Surg Oncol, 2004, 11:399-406.
二级参考文献29
-
1叶丽虹,秦宵然,张晓东,王洪辉,蒋斯明,王长晔,吴晶辉,朱惠芳,赵轼轩,蔡兵.应用SCID鼠筛选肝癌转移性亚克隆及M-H7402亚细胞系的建立[J].南开大学学报(自然科学版),2004,37(3):120-124. 被引量:4
-
2Le Naour F. Contribution of proteomics to tumor immunology.Proteomics, 2001,1 (10): 1295~1302.
-
3Ornstein D K, Petricoin E F 3rd. Proteomics to diagnose human tumors and provide prognostic information. Oncology ( Huntingt ), 2004, 18(4) :521~529; discussion 529~532.
-
4Pandey A, Mann M. Proteomics to study genes and genomes. Nature,2000, 405 (6788): 837~846.
-
5Ye L-H, Kishi H, Nakamura A, Okagaki T, Tanaka T, Oiwa K,Kohama K. Myosin light chain kinase of smooth muscle stimulates myosin ATPase activity without phosphorylating myosin light chain. Proc Natl Acad Sci USA, 1999,96: 6666~6671.
-
6Hughes J A, Cooke-Yarborough C M, Chadwick N C, Schevzov G,Arbuckle S M, Gunning P, Weinberger R P. High-molecular-weight tropomyosins localize to the contractile rings of dividing CNS cells but are absent from malignant pediatric and adult CNS tumors. Glia, 2003,42 (1): 25~35.
-
7Franzen B, Linder S, Uryu K, Alaiya A A, Hirano T, Kato H, Auer G. Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer, 1996,73 (7): 909~913.
-
8Raval G N, Bharadwaj S, Levine E A, Willingham M C, Geary R L,Kute T, Prasad G L. Loss of expression of tropomyosin-1, a novel class Ⅱ tumor suppressor that induces anoikis, in primary breast tumors.Oncogene, 2003, 22 (40): 6194~6203.
-
9Pawlak G, McGarvey T W, Nguyen T B, Tomaszewski J E,Puthiyaveettil R, Malkowicz S B, Helfman D M. Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. Int J Cancer, 2004,110 (3): 368~373.
-
10Jiang D F,Ying W T,Lu Y L,Zhai Y,Liu W L,Zhu Y P, Qiu Z Y,Qian X H, He F C. Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics, 2003, 3: 724~737.
共引文献29
-
1白瑞霞,王文礼.蛋白质组学在肝癌研究中的应用[J].内蒙古医学院学报,2006,28(S1):51-54. 被引量:1
-
2赵可新,胡建平,单靖珊,马骐,葛军.盐酸吉西他滨临床应用进展[J].中国医药导报,2006,3(36):13-15. 被引量:12
-
3吕磊,刘志强,刘淑莹,刘丽.COC_1/DDP亚细胞中波形纤维蛋白的肽质谱指纹分析[J].宝鸡文理学院学报(自然科学版),2006,26(4):279-281.
-
4徐刚,王兴鹏,赵国旗,吴恺,赵崧.塞来昔布对胰腺癌的放疗增敏作用及其机制研究[J].中华消化杂志,2006,26(11):753-757. 被引量:7
-
5许东奎,赵平.COX-2和NSAIDs与胰腺癌的关系[J].中国肿瘤临床与康复,2006,13(6):565-567.
-
6徐刚,王兴鹏,吴恺,赵崧.赛来昔布联合吉西他滨对胰腺癌细胞侵袭转移的抑制作用及其机制[J].中华肝胆外科杂志,2007,13(3):187-191. 被引量:4
-
7张群华,倪泉兴.努力推进胰腺癌规范治疗[J].中华医学杂志,2007,87(16):1086-1087. 被引量:8
-
8李斌,王济明.消化系统肿瘤转移的蛋白质组学研究进展[J].现代肿瘤医学,2007,15(8):1190-1191.
-
9王国平,张宁刚,杨金亮,何燕,瞿燕春,蒋沙沙,路泽军,罗锋.融合细胞株Eahy926与亲本人肺腺癌细胞株A549差异表达蛋白的蛋白质组学分析[J].中国生物化学与分子生物学报,2007,23(8):652-659. 被引量:5
-
10冯雪萍,刘伟,肖志强,黄生鹏,李建玲,易红,张鹏飞,段朝军.近致死量照射CNE1后存活克隆生物学性状初步分析[J].中国耳鼻咽喉颅底外科杂志,2007,13(4):245-249. 被引量:2
-
1王旭亮,江智茂,杨丽华,李彩灵,桂耀庭,蔡志明.UTX基因上调对肾癌786-O细胞增殖的影响[J].国际泌尿系统杂志,2014,34(4):489-492. 被引量:1
-
2吴建平,蒋芳,俞力,潘晓晖.PRDX1在食管鳞癌中的表达及其临床意义[J].河北医学,2015,21(8):1408-1411. 被引量:1
-
3沈徐宁,彭玉平,李海强,周元,李进,朱奕.siRNA沉默Twist基因对结直肠癌细胞顺铂化疗敏感性的影响[J].中华肿瘤防治杂志,2016,23(8):493-498. 被引量:6
-
4曹朴,贾瑞鹏,许露伟,薛建新,吴剑平,梁凯,李文成,苏江浩.西乐葆对雄激素剥夺治疗的前列腺癌患者血清PSA的影响[J].解剖与临床,2010(4):270-272.
-
5程小丽,李旭,陈葳,傅伟.CD_(44)和E-cadherin表达与肾癌细胞增殖潜能的研究[J].中华泌尿外科杂志,2000,21(4):202-204. 被引量:3
-
6吴明富,黎婧,刘丽江.MiR-200c调控ZEB1抑制子宫内膜癌细胞增殖和侵袭[J].武汉大学学报(医学版),2016,37(5):752-756. 被引量:1
-
7张坚,徐卓群,胡强,仇学文,王志荣.选择性环氧合酶2抑制剂对人膀胱癌细胞T24增殖和凋亡的作用[J].癌症,2007,26(4):377-381. 被引量:10
-
8邱传珍,刘鹏,杨少春,凌峻.脑膜尾征、Ki-67与脑膜瘤良恶性的相关研究[J].中外医疗,2012,31(29):67-68. 被引量:1
-
9赵正飞,徐亮.P27与AIF调控结直肠癌细胞凋亡的研究进展[J].西南军医,2014,16(1):94-97.
-
10姜冀,宋央央,舒琦瑾.中药在肿瘤细胞凋亡途径方面的研究进展[J].黑龙江中医药,2014,43(2):78-80.